Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
p21 (RAC1) activated kinase 1 | 0.494 | 0.808 | 1.3E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
DNA polymerase eta | 0.663 | 0.462 | 3.5E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ERCC excision repair 3, TFIIH core complex helicase subunit | 0.504 | 0.846 | 3.4E-11 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
transformation/transcription domain associated protein | 0.572 | 0.692 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
XPA, DNA damage recognition and repair factor | 0.520 | 0.846 | 7.9E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
damage specific DNA binding protein 2 | 0.576 | 0.654 | 7.4E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cutaneous malignant melanoma/dysplastic nevus | 0.670 | 0.385 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1983 | 2017 | |||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
CD63 molecule | 0.542 | 0.731 | 1.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2011 | ||||||||
|
thymosin beta 10 | 0.641 | 0.577 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
S100 calcium binding protein A1 | 0.421 | 0.846 | 6.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.963 | 27 | 42 | 1994 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2002 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.949 | 79 | 10 | 1995 | 2016 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.200 | None | 1.000 | 14 | 2 | 1995 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2006 |